Kodiak Sciences Inc. (KOD) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	267.1	136.0	49.2	7.6	3.5	3.1
General and administrative				7.6	3.5	3.1
Research and development				18.8	22.0	14.1
Other operating expenses	-267.1	-136.0	-49.2
EBITDA [+]				-25.9	-25.0	-16.9
EBITDA growth			-100.0%	3.7%	47.8%
Depreciation and amortization				0.5	0.5	0.3
EBIT [+]	0.0	0.0	0.0	-26.4	-25.5	-17.2
EBIT growth			-100.0%	3.3%	48.8%
Interest expense, net [+]	-0.3	-2.9	-1.6	4.9	1.2	0.0
Interest expense	0.0	0.0	0.0	5.5	1.2	0.0
Interest income	0.3	2.9	1.6	0.6	0.0
Other income (expense), net [+]	-267.2	-136.0	-48.9	-10.2	-1.3	0.0
Gain (loss) on debt retirement				-5.5
Other				-4.7	-1.3	0.0
Pre-tax income	-266.9	-133.1	-47.4	-41.4	-27.9	-17.1
Income taxes	0.1	0.0	0.0	0.0	0.0	0.0
Tax rate			0.0%	0.0%	0.0%	0.0%
Net income	-267.0	-133.1	-47.4	-41.4	-27.9	-17.1

Basic EPS [+]	($5.16)	($2.91)	($1.25)	($2.77)	($3.72)	($2.38)
Growth	77.2%	132.5%	-54.8%	-25.6%	56.5%
Diluted EPS [+]	($5.16)	($2.91)	($1.25)	($2.77)	($3.72)	($2.38)
Growth	77.2%	132.5%	-54.8%	-25.6%	56.5%

Shares outstanding (basic) [+]	51.8	45.7	37.9	15.0	7.5	7.2
Growth	13.2%	20.8%	152.8%	99.3%	4.2%
Shares outstanding (diluted) [+]	51.8	45.7	37.9	15.0	7.5	7.2
Growth	13.2%	20.8%	152.8%	99.3%	4.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.